---
title: "ZyVersa Therapeutics (ZVSA.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ZVSA.US/norm.md"
symbol: "ZVSA.US"
name: "ZyVersa Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/ZVSA.US.md"
datetime: "2026-03-15T02:04:20.859Z"
locales:
  - [en](https://longbridge.com/en/quote/ZVSA.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ZVSA.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ZVSA.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ZVSA.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ZVSA.US/norm.md)


# ZyVersa Therapeutics (ZVSA.US) — 财务报表

## 利润表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -2.56 | -0.4593 | -0.7264 | -0.7140 | -2.43 |
| ROE | 2816.39% | -124.32% | -108.46% | -73.17% | -122.77% |
| Revenue | - | - | - | - | - |
| Net income | -19.81M | -2.21M | -2.26M | -1.42M | -2.40M |
| Operating income | -2.10M | -2.04M | -2.14M | -1.29M | -2.27M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.04M | 19.64M | 20.99M | 20.60M | 19.42M |
| Leverage | -0.0887 | 3.22 | 2.58 | 2.42 | 2.76 |
| BVPS | -1.45 | 1.25 | 3.17 | 3.40 | 6.54 |
| Turnover | - | - | - | - | - |
| Cash & STI | 527978.00 | 72086.00 | 1.61M | 1.53M | 122921.00 |
| Inv & Rec | - | - | - | - | - |
| LT assets | - | - | - | 0.0000 | - |
| Net debt | -527978.00 | -72086.00 | -1.61M | -1.53M | -122921.00 |

## 现金流量表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -1.41M | -1.52M | -1.77M | -1.22M | -614141.00 |
| Investing CF | - | - | - | - | - |
| Financing CF | 1.86M | -17718.00 | 1.85M | 2.63M | 617576.00 |
| Free CF | -1.16M | -510443.00 | -809747.00 | -879372.00 | 545472.00 |
| OCF coverage | - | - | - | - | - |
| Repaid & issued | - | - | - | - | - |
| CapEx | - | - | - | - | - |